Patent · US Active

Conjugates and conjugating reagents

US11027022B2 · kind B2 · utility

0Cited by
1References
13Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 19, 2017
Grant dateJun 8, 2021
Priority date
Expiry dateAug 6, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A conjugate of a protein or peptide conjugated to a therapeutic, diagnostic or labelling agent via a linker, in which the linker includes a protein or peptide bonding portion having the general formula: in which Pr represents said protein or peptide, each Nu represents a nucleophile present in or attached to the protein or peptide, each of A and B independently represents a C1-4alkylene or alkenylene chain, and W′ represents an electron withdrawing group or a group obtained by reduction of an electron withdrawing group; and in which the linker also includes a cyclodextrin. The invention also provides reagents for making such conjugates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.